Tilray Brands Inc. | Small-cap | Healthcare
$1.12
5.66%
| Tilray Brands Stock Comparison:
Tilray Brands vs ZoetisTilray Brands vs Haleon Plc - ADRTilray Brands vs BioCrystTilray Brands vs Phibro Animal HealthTilray Brands vs BGMTilray Brands vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: May 2025

Income Metrics

Revenue 224.5M
Gross Profit 67.6M 30.12%
Operating Income -12.7M -5.64%
Net Income -1.3B -564.68%

Balance Sheet Metrics

Total Assets 2.1B
Total Liabilities 584.8M
Shareholders Equity 1.5B
Debt to Equity 0.39

Cash Flow Metrics

Operating Cash Flow -1.4B
Free Cash Flow -19.1M

Revenue & Profitability Trend

Tilray Brands Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i821.3M788.9M627.1M628.4M513.1M
Cost of Goods Sold i580.7M565.6M480.2M511.6M389.9M
Gross Profit i240.6M223.4M147.0M116.8M123.2M
Gross Margin % i29.3%28.3%23.4%18.6%24.0%
Operating Expenses
Research & Development i284.0K635.0K682.0K1.5M830.0K
Selling, General & Administrative i259.5M250.7M231.0M233.4M155.7M
Other Operating Expenses i-----
Total Operating Expenses i259.8M251.4M231.7M234.9M156.5M
Operating Income i-107.8M-112.8M-178.2M-233.3M-68.6M
Operating Margin % i-13.1%-14.3%-28.4%-37.1%-13.4%
Non-Operating Items
Interest Income i11.4M12.8M33.0M11.7M2.9M
Interest Expense i41.3M49.3M46.6M39.7M30.9M
Other Non-Operating Income-2.2B-99.8M-1.3B-179.5M-248.4M
Pre-tax Income i-2.3B-249.0M-1.5B-440.7M-345.0M
Income Tax i-121.0M-26.6M-7.2M-6.5M-9.0M
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-2.2B-222.4M-1.4B-434.1M-336.0M
Net Margin % i-265.6%-28.2%-230.1%-69.1%-65.5%
Key Metrics
EBITDA i19.4M-47.8M-313.0M101.9M-159.2M
EPS (Basic) i$-2.46$-0.33$-2.35$-0.90$-1.25
EPS (Diluted) i$-2.46$-0.33$-2.35$-0.90$-1.25
Basic Shares Outstanding i890326017673951515617982589482368889446440641
Diluted Shares Outstanding i890326017673951515617982589482368889446440641

Income Statement Trend

Tilray Brands Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i221.7M228.3M206.6M415.9M488.5M
Short-term Investments i34.7M32.2M241.9M0-
Accounts Receivable i121.5M101.7M86.2M95.3M87.3M
Inventory i270.9M252.1M200.6M245.5M256.4M
Other Current Assets34.1M31.3M37.7M46.8M48.9M
Total Current Assets i688.6M677.7M773.0M803.5M883.6M
Non-Current Assets
Property, Plant & Equipment i343.2M318.6M191.4M267.5M268.4M
Goodwill i1.5B4.9B5.0B6.6B7.3B
Intangible Assets i21.4M915.5M973.8M1.3B1.6B
Long-term Investments-----
Other Non-Current Assets11.1M5.4M222.0K314.0K8.3M
Total Non-Current Assets i1.4B3.5B3.5B4.6B5.1B
Total Assets i2.1B4.2B4.3B5.4B6.0B
Liabilities
Current Liabilities
Accounts Payable i107.3M105.4M70.8M68.6M57.7M
Short-term Debt i28.9M39.0M224.3M92.6M49.6M
Current Portion of Long-term Debt-----
Other Current Liabilities16.1M18.3M18.0M30.3M138.8M
Total Current Liabilities i280.3M299.2M433.0M280.3M401.2M
Non-Current Liabilities
Long-term Debt i299.8M348.4M365.9M531.2M889.1M
Deferred Tax Liabilities i3.7M130.9M167.4M196.6M265.8M
Other Non-Current Liabilities855.0K90.0K11.1M191.0K3.9M
Total Non-Current Liabilities i304.4M479.3M544.3M728.0M1.2B
Total Liabilities i584.8M778.5M977.3M1.0B1.6B
Equity
Common Stock i106.0K83.0K66.0K53.0K46.0K
Retained Earnings i-4.8B-2.7B-2.4B-962.9M-486.0M
Treasury Stock i0----
Other Equity-----
Total Shareholders Equity i1.5B3.4B3.3B4.4B4.5B
Key Metrics
Total Debt i328.7M387.3M590.1M623.8M938.7M
Working Capital i408.3M378.5M340.0M523.2M482.4M

Balance Sheet Composition

Tilray Brands Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-2.2B-222.4M-1.4B-434.1M-336.0M
Depreciation & Amortization i133.5M126.9M130.1M154.6M67.8M
Stock-Based Compensation i24.3M31.8M39.6M36.0M17.4M
Working Capital Changes i-31.4M-22.2M-8.8M-51.6M-64.1M
Operating Cash Flow i-2.1B-69.8M-1.1B-371.9M-278.4M
Investing Activities
Capital Expenditures i-26.1M-20.7M-16.5M-21.9M-32.3M
Acquisitions i-18.1M-60.6M-26.7M326.0K66.6M
Investment Purchases i---241.9M00
Investment Sales i--008.4M
Investing Cash Flow i-44.2M-81.4M-285.1M-21.5M46.1M
Financing Activities
Share Repurchases i00-1.2M-8.7M0
Dividends Paid i-----
Debt Issuance i3.4M54.2M146.3M0102.8M
Debt Repayment i-18.7M-132.6M-209.8M-133.0M-65.6M
Financing Cash Flow i133.5M-75.2M70.2M122.8M124.2M
Free Cash Flow i-127.5M-60.2M-12.9M-211.3M-83.6M
Net Change in Cash i-2.1B-226.3M-1.3B-270.7M-108.1M

Cash Flow Trend

Tilray Brands Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -0.46
Forward P/E -16.00
Price to Book 0.78
Price to Sales 1.52
PEG Ratio -16.00

Profitability Ratios

Profit Margin -266.25%
Operating Margin -6.38%
Return on Equity -88.44%
Return on Assets -2.13%

Financial Health

Current Ratio 2.46
Debt to Equity 22.07
Beta 2.08

Per Share Data

EPS (TTM) $-2.46
Book Value per Share $1.43
Revenue per Share $0.92

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
tlry1.2B-0.460.78-88.44%-266.25%22.07
Zoetis 65.3B25.3613.1452.77%27.83%137.01
Haleon Plc - ADR 45.4B21.935.599.38%13.81%53.41
BioCryst 1.7B-18.40-3.9318.68%-6.41%-1.75
Phibro Animal Health 1.6B33.295.6217.80%3.72%269.85
BGM 1.5B15.003.98-16.52%-26.32%0.22

Financial data is updated regularly. All figures are in the company's reporting currency.